Analysis of correlations between patient-oriented SCORAD (PO-SCORAD) and other assessment scores of atopic dermatitis severity and quality of life

Dermatology

Volumn 229, Issue 3, 2014, Pages 248-255

  Coutanceau, Christine ^a   Stalder, Jean François ^b  

^a Centre d'Immunologie Pierre Fabre   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

Atopic dermatitis; Eczema score; Patient oriented; Patient Oriented Eczema measure; Quality of life; Scoring of atopic dermatitis index; Self Administered Eczema area and severity index; Self assessment score

Indexed keywords

ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; ANTIINFECTIVE AGENT; CALCINEURIN INHIBITOR; CORTICOSTEROID; EMOLLIENT AGENT; DERMATOLOGICAL AGENT;

ADOLESCENT; ADULT; ALLERGIC ASTHMA; ALLERGIC RHINITIS; ANTIBIOTIC THERAPY; ARTICLE; ATOPIC DERMATITIS; CHILD; CLINICAL ASSESSMENT TOOL; CORRELATION COEFFICIENT; CORTICOSTEROID THERAPY; CREAM; DERMATOLOGY LIFE QUALITY INDEX; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; OPEN STUDY; PATIENT ORIENTED ECZEMA MEASURE; PATIENT ORIENTED SCORING OF ATOPIC DERMATITIS INDEX; PROSPECTIVE STUDY; QUALITY OF LIFE; QUALITY OF LIFE INDEX; QUESTIONNAIRE; RATING SCALE; SCORING SYSTEM; SELF ADMINISTERED ECZEMA AREA AND SEVERITY INDEX; SELF EVALUATION; SKIN EXAMINATION; SYSTEMIC THERAPY; ADAPTIVE BEHAVIOR; AGE; AGED; CLINICAL TRIAL; COMPARATIVE STUDY; CONFIDENCE INTERVAL; DERMATITIS, ATOPIC; EUROPE; EVALUATION STUDY; MENTAL STRESS; MIDDLE AGED; PRESCHOOL CHILD; PSYCHOLOGY; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DIFFERENCE; YOUNG ADULT;

ADAPTATION, PSYCHOLOGICAL; ADOLESCENT; ADULT; AGE FACTORS; AGED; CHILD; CHILD, PRESCHOOL; CONFIDENCE INTERVALS; DERMATITIS, ATOPIC; DERMATOLOGIC AGENTS; EUROPE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; RISK ASSESSMENT; SELF-ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX FACTORS; STRESS, PSYCHOLOGICAL; YOUNG ADULT;

EID: 84913607934     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000365075     Document Type: Article

References (25)

1. Ersser SJ, Latter S, Sibley A, Satherley PA, Welbourne S: Psychological and educational interventions for atopic eczema in children. Cochrane Database Syst Rev 2007; 3: CD004054.
2. Zuberbier T, Orlow SJ, Paller AS, Taieb A, Allen R, Hernanz-Hermosa JM, Ocampo-Candiani J, Cox M, Langeraar J, Simon JC: Patient perspectives on the management of atopic dermatitis. J Allergy Clin Immunol 2006; 118: 226-232.
3. Charman CR, Venn AJ, Williams HC: The Patient-Oriented Eczema Measure: development and initial validation of a new tool for measuring atopic eczema severity from the patients' perspective. Arch Dermatol 2004; 140: 1513-1519.
4. Housman TS, Patel MJ, Camacho F, Feldman SR, Fleischer AB Jr, Balkrishnan R: Use of the Self-Administered Eczema Area and Severity Index by parent caregivers: results of a validation study. Br J Dermatol 2002; 147: 1192-1198.
5. Vourc'h-Jourdain M, Barbarot S, Taieb A, Diepgen T, Ambonati M, Durosier V, Sibaud V, Stalder JF: Patient-oriented SCORAD: a self-assessment score in atopic dermatitis. A preliminary feasibility study. Dermatology 2009; 218: 246-251.
6. Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology 1993; 186: 23-31.
7. Schmitt J, Langan S, Deckert S, Svensson A, von Kobyletzki L, Thomas K, Spuls P: Harmonising Outcome Measures for Atopic Dermatitis (HOME) Initiative. Assessment of clinical signs of atopic dermatitis: a systematic review and recommendation. J Allergy Clin Immunol 2013; 132: 1337-1347.
8. Rehal B, Armstrong AW: Health outcome measures in atopic dermatitis: a systematic review of trends in disease severity and qualityof-life instruments 1985-2010. PLoS One 2011; 6:e17520
9. erratum in PLoS One 2011; 6: 10.1371.
10. Stalder JF, Barbarot S, Wollenberg A, Holm EA, De Raeve L, Seidenari S, Oranje A, Deleuran M, Cambazard F, Svensson A, Simon D, Benfeldt E, Reunala T, Mazereeuv J, Boralevi F, Kunz B, Misery L, Mortz CG, Darsow U, Gelmetti C, Diepgen T, Ring J, Moehrenschlager M, Gieler U, Taïeb A; PO-SCORAD Investigators Group: Patient-oriented SCORAD (PO-SCORAD): a new self-assessment scale in atopic dermatitis validated in Europe. Allergy 2011; 66: 1114-1121.
11. Lewis-Jones S: Quality of life and childhood atopic dermatitis: the misery of living with childhood eczema. Int J Clin Pract 2006; 60: 984-992.
12. Finlay AY, Khan GK: Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-216.
13. Lawson V, Lewis-Jones MS, Finlay AY, Reid P, Owens RG: The family impact of childhood atopic dermatitis: the Dermatitis Family Impact Questionnaire. Br J Dermatol 1998; 138: 107-113.
14. Ben-Gashir MA, Seed PT, Hay RJ: Are quality of family life and disease severity related in childhood atopic dermatitis? J Eur Acad Dermatol Venereol 2002; 16: 455-462.
15. Van Valburg RW, Willemsen MG, Dirven-Meijer PC, Oranje AP, van der Wouden JC, Moed H: Quality of life measurement and its relationship to disease severity in children with atopic dermatitis in general practice. Acta Derm Venereol 2011; 91: 147-151.
16. Haeck IM, ten Berge O, van Velsen SG, de Bruin-Weller MS, Bruijnzeel-Koomen CA, Knol MJ: Moderate correlation between quality of life and disease activity in adult patients with atopic dermatitis. J Eur Acad Dermatol Venereol 2012; 26: 236-241.
17. Darsow U, Wollenberg A, Simon D, Taieb A, Werfel T, Oranje A, Gelmetti C, Svensson A, Deleuran M, Calza AM, Giusti F, Lübbe J, Seidenari S, Ring J; European Task Force on Atopic Dermatitis/EADV Eczema Task Force: ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis. J Eur Acad Dermatol Venereol 2010; 24: 317-328.
18. Hanifin JM, Cooper KD, Ho VC, Kang S, Krafchik BR, Margolis DJ, Schachner LA, Sidbury R, Whitmore SE, Sieck CK, Van Voorhees AS: Guidelines of care for atopic dermatitis, developed in accordance with the American Academy of Dermatology (AAD)/American Academy of Dermatology Association 'Administrative Regulations for Evidence-Based Clinical Practice Guidelines'. J Am Acad Dermatol 2004; 50: 391-404.
19. Loden M, Andersson AC, Andersson C, Frodin T, Oman H, Lindberg M: Instrumental and dermatologist evaluation of the effect of glycerine and urea on dry skin in atopic dermatitis. Skin Res Technol 2001; 7: 209-213.
20. Kantor I, Milbauer J, Posner M, Weinstock IM, Simon A, Thormahlen S: Efficacy and safety of emollients as adjunctive agents in topical corticosteroid therapy for atopic dermatitis. Today Ther Trends 1993; 11: 157-166.
21. Coutanceau C, Boisson S, Stalder J-F: Analysis of correlations between patient-oriented SCORAD (PO-SCORAD), other assessment scales of atopic dermatitis severity and specific quality of life scales. Nouv Dermatol 2011; 30: 456-461.
22. Lewis-Jones MS, Finlay AY, Dykes PJ: The Infants' Dermatitis Quality of Life Index. Br J Dermatol 2001; 144: 104-110.
23. Finlay AY, Lewis-Jones MS, Sharp JL, Dykes PJ: Children's Dermatology Life Quality Index: cartoon version validation. Br J Dermatol 1998; 139: 67.
24. Lewis-Jones MS, Finlay AY: The Children's Dermatology Life Quality Index (CDLQI): initial validation and practical use. Br J Dermatol 1995; 132: 942-949.
25. Kunz B, Oranje AP, Labrèze L, Stalder JF, Ring J, Taïeb A: Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology 1997; 195: 10-19.